CLIC4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.189400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.088800E-01
Normal-vs-Stage2
7.922000E-01
Normal-vs-Stage3
3.921600E-01
Normal-vs-Stage4
5.726600E-01
Stage1-vs-Stage2
3.867400E-01
Stage1-vs-Stage3
8.740200E-01
Stage1-vs-Stage4
8.847600E-02
Stage2-vs-Stage3
5.527200E-01
Stage2-vs-Stage4
2.729600E-01
Stage3-vs-Stage4
1.503410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.817400E-01
Normal-vs-AfricanAmerican
9.825400E-01
Normal-vs-Asian
4.709200E-01
Caucasian-vs-AfricanAmerican
5.418200E-01
Caucasian-vs-Asian
3.505200E-01
AfricanAmerican-vs-Asian
3.411600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.762600E-01
Normal-vs-Female
8.016800E-01
Male-vs-Female
3.779200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.165800E-01
Normal-vs-Age(41-60Yrs)
9.914000E-01
Normal-vs-Age(61-80Yrs)
6.518000E-01
Normal-vs-Age(81-100Yrs)
5.161200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.704240E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.879000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.109400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.127450E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.025400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.794800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.564000E-01
Normal-vs-Daily Drinker
2.391800E-01
Normal-vs-Weekly Drinker
8.545600E-01
Normal-vs-Occasional Drinker
8.041800E-01
Normal-vs-Social Drinker
9.028800E-01
Non Drinker-vs-Daily Drinker
8.467400E-01
Non Drinker-vs-Weekly Drinker
1.486150E-01
Non Drinker-vs-Occasional Drinker
3.233400E-01
Non Drinker-vs-Social Drinker
1.487750E-01
Daily Drinker-vs-Weekly Drinker
1.437020E-01
Daily Drinker-vs-Occasional Drinker
2.819800E-01
Daily Drinker-vs-Social Drinker
1.316620E-01
Weekly Drinker-vs-Occasional Drinker
8.620200E-01
Weekly Drinker-vs-Social Drinker
6.371400E-01
Occasional Drinker-vs-Social Drinker
5.340200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.281800E-01
Normal-vs-Grade 2
3.241400E-01
Normal-vs-Grade 3
5.071200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.090200E-02
Grade 1-vs-Grade 3
1.537790E-01
Grade 1-vs-Grade 4
8.281800E-01
Grade 2-vs-Grade 3
6.494800E-01
Grade 2-vs-Grade 4
3.241400E-01
Grade 3-vs-Grade 4
5.071200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.657800E-01
Normal-vs-NonDiabetic
5.760800E-01
Diabetic-vs-NonDiabetic
5.872000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.090200E-01
Normal-vs-NoPancreatitis
6.621600E-01
Pancreatitis-vs-NoPancreatitis
7.922600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.114600E-01
Normal-vs-N1
7.891800E-01
N0-vs-N1
2.393000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.778400E-01
Normal-vs-TP53-NonMutant
3.955200E-01
TP53-Mutant-vs-TP53-NonMutant
2.729600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
